Retention of patients in opioid substitution treatment: A systematic review.

BACKGROUND:Retention in opioid substitution (OST) treatment is associated with substantial reductions in all cause and overdose mortality. This systematic review aims to identify both protective factors supporting retention in OST, and risk factors for treatment dropout. METHODS:A systematic search...

Full description

Bibliographic Details
Main Authors: Aisling Máire O'Connor, Gráinne Cousins, Louise Durand, Joe Barry, Fiona Boland
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0232086
id doaj-5d7adf324cd747988ea35927fe0ea29e
record_format Article
spelling doaj-5d7adf324cd747988ea35927fe0ea29e2021-03-03T21:44:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01155e023208610.1371/journal.pone.0232086Retention of patients in opioid substitution treatment: A systematic review.Aisling Máire O'ConnorGráinne CousinsLouise DurandJoe BarryFiona BolandBACKGROUND:Retention in opioid substitution (OST) treatment is associated with substantial reductions in all cause and overdose mortality. This systematic review aims to identify both protective factors supporting retention in OST, and risk factors for treatment dropout. METHODS:A systematic search was performed using MEDLINE, Embase, PsycInfo, CINAHL and Web of Science (January 2001 to October 2019). Randomised controlled trials (RCTs) and observational cohort studies reporting on retention rates and factors associated with retention in OST were included. Factors associated with treatment retention and dropout were explored according to the Maudsley Addiction Profile. A narrative synthesis is provided. RESULTS:67 studies were included in this review (4 RCTs and 63 observational cohort studies; N = 294,592), all assessing factors associated with retention in OST or treatment dropout. The median retention rate across observational studies was approximately 57% at 12 months, which fell to 38.4% at three years. Studies included were heterogeneous in nature with respect to treatment setting, type of OST, risk factor assessment, ascertainment of outcome and duration of follow-up. While the presence of such methodological heterogeneity makes it difficult to synthesise results, there is limited evidence to support the influence of a number of factors on retention, including age, substance use, OST drug dose, legal issues, and attitudes to OST. CONCLUSIONS:Younger age, substance use particularly cocaine and heroin use, lower doses of methadone, criminal activity/incarceration, and negative attitudes to MMT appear to be associated with reduced retention in OST. A consensus definition of retention is required to allow for comparability across future studies.https://doi.org/10.1371/journal.pone.0232086
collection DOAJ
language English
format Article
sources DOAJ
author Aisling Máire O'Connor
Gráinne Cousins
Louise Durand
Joe Barry
Fiona Boland
spellingShingle Aisling Máire O'Connor
Gráinne Cousins
Louise Durand
Joe Barry
Fiona Boland
Retention of patients in opioid substitution treatment: A systematic review.
PLoS ONE
author_facet Aisling Máire O'Connor
Gráinne Cousins
Louise Durand
Joe Barry
Fiona Boland
author_sort Aisling Máire O'Connor
title Retention of patients in opioid substitution treatment: A systematic review.
title_short Retention of patients in opioid substitution treatment: A systematic review.
title_full Retention of patients in opioid substitution treatment: A systematic review.
title_fullStr Retention of patients in opioid substitution treatment: A systematic review.
title_full_unstemmed Retention of patients in opioid substitution treatment: A systematic review.
title_sort retention of patients in opioid substitution treatment: a systematic review.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description BACKGROUND:Retention in opioid substitution (OST) treatment is associated with substantial reductions in all cause and overdose mortality. This systematic review aims to identify both protective factors supporting retention in OST, and risk factors for treatment dropout. METHODS:A systematic search was performed using MEDLINE, Embase, PsycInfo, CINAHL and Web of Science (January 2001 to October 2019). Randomised controlled trials (RCTs) and observational cohort studies reporting on retention rates and factors associated with retention in OST were included. Factors associated with treatment retention and dropout were explored according to the Maudsley Addiction Profile. A narrative synthesis is provided. RESULTS:67 studies were included in this review (4 RCTs and 63 observational cohort studies; N = 294,592), all assessing factors associated with retention in OST or treatment dropout. The median retention rate across observational studies was approximately 57% at 12 months, which fell to 38.4% at three years. Studies included were heterogeneous in nature with respect to treatment setting, type of OST, risk factor assessment, ascertainment of outcome and duration of follow-up. While the presence of such methodological heterogeneity makes it difficult to synthesise results, there is limited evidence to support the influence of a number of factors on retention, including age, substance use, OST drug dose, legal issues, and attitudes to OST. CONCLUSIONS:Younger age, substance use particularly cocaine and heroin use, lower doses of methadone, criminal activity/incarceration, and negative attitudes to MMT appear to be associated with reduced retention in OST. A consensus definition of retention is required to allow for comparability across future studies.
url https://doi.org/10.1371/journal.pone.0232086
work_keys_str_mv AT aislingmaireoconnor retentionofpatientsinopioidsubstitutiontreatmentasystematicreview
AT grainnecousins retentionofpatientsinopioidsubstitutiontreatmentasystematicreview
AT louisedurand retentionofpatientsinopioidsubstitutiontreatmentasystematicreview
AT joebarry retentionofpatientsinopioidsubstitutiontreatmentasystematicreview
AT fionaboland retentionofpatientsinopioidsubstitutiontreatmentasystematicreview
_version_ 1714815371385503744